Purchase Order 75N95024P00465

Award Date 8/9/24
Potential Completion Date 11/29/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $915,668.54, is for the delivery of unspecified medical imaging products and services to NIDA. The award is not set aside for small businesses. As a prime contractor, Revvity Health Sciences has provided a variety of medical devices...
This firm fixed-price delivery order was awarded to Revvity Health Sciences, Inc. by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. federal government. The contract, valued at $106,514.11, is for the provision of a MicroBeta 2 plate reader with 6 detectors. It was awarded under the General Services Administration's (GSA) Scientific Equipment and Services schedule (FSS-66) and does not utilize any set-aside designation. Revvity Health Sciences is a for-profit...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Revvity Health Sciences, Inc. for the purchase of 100,000 "CAMP GI KIT" test kits. The $19,010.65 firm fixed-price purchase order has a completion date of June 27, 2025. The contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that has previously provided medical devices and equipment to various federal agencies including the NIH,...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 26, 2016. The contract has a ceiling value of $320,095.60 and a completion date of January 30, 2017. The contract was not set aside for any specific business type. Revvity Health Sciences, a for-profit manufacturer, will provide medical...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract is valued at $10,652.49 and has a period of performance from April 24, 2024 to April 23, 2025. The contract does not have a set-aside designation. Revvity Health Sciences has a history of providing a variety...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $17,185 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to deliver 100,000 points worth of HTRF CAMP GI KIT assay kits. The kits will support drug abuse research programs at the National Institute on Drug Abuse. Delivery of the assay kits will take place in Baltimore, Maryland over the course of a one year ordering period. No subcontractors or...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $257,419.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the supply of a ViewLux HTS Imager from PerkinElmer Health Sciences Inc. This equipment will be used by the National Center for Advancing Translational Sciences (NCATS) to support its liquid dispensing high-throughput assays. The contract does not have a set-aside designation. Revvity Health Sciences,...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for a multimodal plate reader. The award has a ceiling value of $75,421.69 and an ultimate completion date of March 3, 2017. The contract does not have a set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging...
This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $373,274.40 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for a preclinical in-vivo optical imaging system for the NIH Mouse Imaging Facility (MIF). The contract was awarded on September 19, 2019, with a completion date of September 18, 2020. Revvity Health Sciences, Inc. is a for-profit organization and manufacturer of medical imaging products and...

This federal contract award is to Revvity Health Sciences, Inc. for the delivery of a HTRF GTP GI Bind. Kit - 20K PTS to the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract has a firm fixed price of $20,727.50 and a period of performance through November 29, 2024. This award is not associated with a set-aside program. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products and services for government agencies. The company has previously provided a variety of laboratory equipment and instrumentation to NIDA, the Centers for Disease Control and Prevention, and other federal customers through prime contracts, subcontracts, and indefinite delivery vehicles. This particular award represents a direct purchase order between NIDA and Revvity Health Sciences for a specialized bioassay product used in drug discovery and development research.

Generated 9/4/24, 9:28 AM